UK regulators on Thursday approved Merck's anti-Covid pill as the country continues to grapple with the virus. The country's health minister Sajid Javid said: "Today is a historic day for our country, as the UK is now the first country in the world to approve an antiviral that can be taken at home for Covid-19.

Britain becomes first country to approve Merck's anti-COVID-19 pill

US drugmaker Merck & Co. on Wednesday announced a deal that could see generic versions of its medication for Covid sufferers widely distributed in poorer countries, in a first during the pandemic.

Merck strikes deal for global access to Covid drug

US drugmaker Merck applied for emergency use authorisation in the United States for its pill to fight against coronavirus. The company had claimed that molnupiravir reduced hospitalisations by 50 per cent.

Merck seeks US FDA's authorisation for COVID-19 pill

India's Hetero Labs said on Friday it sought an emergency use nod from the local regulator for Merck's COVID-19 drug molnupiravir, after interim data from a late-stage trial showed it helped reduce hospitalisations and speed up recovery in mild cases.

India's Hetero seeks emergency use nod for Merck's COVID-19 drug

Merck & Co said on Wednesday (June 9) the U.S. government has agreed to pay about $1.2 billion for 1.7 million courses of its experimental COVID-19 treatment if it is proven to work in an ongoing large trial and authorized by U.

US to need Merck's COVID-19 drug for preparedness, says doctor

A temporary US ban on exports of critical raw materials could limit the production of coronavirus vaccines by companies such as the Serum Institute of India (SII), its chief executive said in a World Bank panel discussion on Thursday.

Indian vaccine giant SII warns of supply hit from US raw materials export ban

merck-co

Merck & Co, News on Merck & Co, stories on Merck & Co, articles on Merck & Co, Merck & Co stories at Wion, Merck & Co news, Merck & Co latest news